Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 6,326–6,350 of 27,380 studies, newest first · page 254 of 1096.

August 2024 11

  1. 2024-08-01

    Primate cerebrospinal fluid CHI3L1 reflects brain TREM2 agonism

    ✓ Peer-reviewed TREM2 and immune genetics Alzheimer's & dementia : the journal of the Alzheimer's Association

    Key finding: We report CSF soluble TREM2 (sTREM2) and CSF chitinase-3-like protein 1 (CHI3L1/YKL-40) as PD biomarkers for the TREM2 agonist hPara.09. +4 more findings

  2. 2024-08-01
  3. 2024-08-01

    Amyloid-Related Imaging Abnormalities in the Era of Anti-Amyloid Beta Monoclonal Antibodies for Alzheimer's Disease: Recent Updates on Clinical and Imaging Features and MRI Monitoring

    ✓ Peer-reviewed Treatments Korean journal of radiology

    Key finding: ARIA results from treatment-related disruption of vascular integrity and increased vascular permeability, leading to the leakage of proteinaceous fluid (ARIA-E) and heme products (ARIA-H).

  4. 2024-08-01

    Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment

    ✓ Peer-reviewed Brain scans and imaging JAMA neurology

    Key finding: In the discovery cohort, the mean (SD) age was 70.9 (8.5) years, 191 (58%) were male, the mean (SD) MMSE score was 27.1 (1.9), and 110 individuals with MCI (33%) converted to dementia (71 to AD dementia). +3 more findings

  5. 2024-08-01

    Parental History of Memory Impairment and β-Amyloid in Cognitively Unimpaired Older Adults

    ✓ Peer-reviewed Treatments JAMA neurology

    Key finding: Of 4413 individuals (mean [SD] age, 71.27 [4.66] years, 2617 women [59.3%]), mean Aβ-PET was elevated in individuals with history of memory impairment in both parents (n = 455; mean [SD] standardized uptake value ratio [SUVR] = 1.12 [0.19]; Wilcoxon P = 1.1 × 10-5) and in those with only maternal history (n = 1772; mean [SD] SUVR = 1.10 [0.19]; Wilcoxon P = 2.70 × 10-5) compared with those with only paternal history (n = 632; mean [SD] SUVR = 1.08 [0.18]; Wilcoxon P = 1.1 × 10-5) or no family history (n = 1554; mean [SD] SUVR = 1.08 [0.19]; Wilcoxon P = 1.1 × 10-5). +2 more findings

  6. 2024-08-01

    ω-3 PUFA for Secondary Prevention of White Matter Lesions and Neuronal Integrity Breakdown in Older Adults: A Randomized Clinical Trial

    ✓ Peer-reviewed Treatments JAMA network open

    Key finding: In this 3-year randomized clinical trial, ω-3 treatment was safe and well-tolerated but failed to reach significant reductions in WML accumulation or neuronal integrity breakdown among all participants, which may be attributable to sample size limitations. +4 more findings

  7. 2024-08-01

    Optical Coherence Tomography Angiography Retinal Imaging Associations With Burden of Small Vessel Disease and Amyloid Positivity in the Brain

    ✓ Peer-reviewed Biomarkers Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society

    Key finding: The associations of lower foveal capillary density with cerebral WMH and amyloid positivity suggest that further research is warranted to evaluate for shared mechanisms of disease between small vessel disease and AD pathologies. +4 more findings

  8. 2024-08-01

    Psychosis in Alzheimer Disease and Elevations in Disease-Relevant Biomarkers

    ✓ Peer-reviewed Biomarkers JAMA psychiatry

    Key finding: In the longitudinal analysis of p-tau181 trajectories of the AD+P group, the group of patients who showed incidence of psychosis over the course of follow-up (AD+P incident) demonstrated an associated increase in plasma p-tau181 levels compared with the group of patients who had psychosis at baseline (AD+P baseline) and showed an associated decrease in plasma p-tau181 levels (F4, 117 = 3.24; P = .01). +3 more findings

  9. 2024-08-01

    Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-β Pathology

    ✓ Peer-reviewed Biomarkers JAMA neurology

    Key finding: Among community-dwelling adults included in this study, higher fragmentation of the 24-hour activity rhythms was associated with greater subsequent Aβ burden, especially in APOE4 carriers. +4 more findings

  10. 2024-08 month only

    Care management improves total cost of care for patients with dementia

    ✓ Peer-reviewed Costs and economics American Journal of Managed Care

    Key finding: A collaborative dementia care program demonstrated significant financial benefit in a managed Medicare population. +3 more findings

  11. 2024-08 month only

July 2024 14

  1. 2024-07-31

    Diagnostic performance of light reflex pupillometry in Alzheimer's disease

    ✓ Peer-reviewed Cognitive tests and assessment Alzheimer's & dementia (Amsterdam, Netherlands)

    Key finding: HIGHLIGHTS: We demonstrated the diagnostic performance of qLRP in Alzheimer's disease.

  2. 2024-07-31

    Plasma biomarkers of neurodegeneration in patients and high risk subjects with Lewy body disease

    ✓ Peer-reviewed Biomarkers NPJ Parkinson's disease

    Key finding: In the PD group, Aβ composite was associated with cognitive function, p-tau181 with motor function and non-motor symptoms, and NfL with cognitive and motor functions and non-motor symptoms. +1 more finding

  3. 2024-07-31

    There Is No Direct Causal Relationship Between Coronary Artery Disease and Alzheimer Disease: A Bidirectional Mendelian Randomization Study

    ✓ Peer-reviewed Tau biomarkers Journal of the American Heart Association

    Key finding: The association between poor cardiovascular health and cognitive decline as well as dementia progression has been inconsistent across studies. +3 more findings

  4. 2024-07-31
  5. 2024-07-30

    CCDC50 mediates the clearance of protein aggregates to prevent cellular proteotoxicity

    ✓ Peer-reviewed Disease mechanisms Autophagy

    Key finding: However, the identity and redundancy of aggrephagy receptors in recognizing substrates remain largely unexplored. +3 more findings

  6. 2024-07-30

    Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease

    ✓ Peer-reviewed Biomarkers Molecular neurodegeneration

    Key finding: Plasma A+/T + individuals showed the highest levels of astrocyte reactivity, Aβ plaque, tau tangle, and axonal degeneration, and the lowest hippocampal volume and temporal-metaROI cortical thickness. +4 more findings

  7. 2024-07-30

    Examining Food Access Equity by Integrating Grocery Store Pricing into Spatial Accessibility Measures

    ✓ Peer-reviewed Risk factors Transportation Research Record: Journal of the Transportation Research Board

    Key finding: However, these measures do not always consider the pricing of food items, which can significantly affect food access for low-income individuals and families. +1 more finding

  8. 2024-07-30
  9. 2024-07-30

    Tracking neuroinflammatory biomarkers in Alzheimer's disease: a strategy for individualized therapeutic approaches?

    ✓ Peer-reviewed Genetics Journal of neuroinflammation

    Key finding: Indeed, in our review, we observed a stage-dependent neuroinflammatory process in the AD brain. +1 more finding

  10. 2024-07-29

    Omnibus proteome-wide association study identifies 43 risk genes for Alzheimer disease dementia

    ✓ Peer-reviewed Genetics American journal of human genetics

    Key finding: The genetic effects of PWAS-identified significant genes are potentially mediated through genetically regulated protein abundance, thus informing the underlying disease mechanisms better than GWAS loci. +1 more finding

  11. 2024-07-29

    Fluvoxamine maleate alleviates amyloid-beta load and neuroinflammation in 5XFAD mice to ameliorate Alzheimer disease pathology

    ✓ Peer-reviewed Biomarkers Frontiers in immunology

    Key finding: Our data suggest that FXN ameliorates AD pathology, by simultaneously targeting two key pathological features: Aβ deposits and neuroinflammation. +4 more findings

  12. 2024-07-29

    Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome

    ✓ Peer-reviewed Biomarkers Neurology

    Key finding: Individuals with DS were more likely to have microbleeds than controls (20% vs 8.9%, p 60 years) and AD clinical stage (12.42% asymptomatic, 27.9% prodromal, 35.09% dementia) were more common in APOE ε4 carriers (26% vs 18.3% noncarriers, p = 0.008), but not associated with vascular risk factors ( p > 0.05). +3 more findings

  13. 2024-07-26

    γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

    ✓ Peer-reviewed Risk genes beyond APOE The Lancet. Neurology

    Key finding: A summary measure of γ-secretase activity (γ-secretase composite [GSC]) was calculated for each variant and compared with clinical history-derived AAO using correlation analyses. +2 more findings

  14. 2024-07-25

    Endoplasmic reticulum unfolded protein response transcriptional targets of XBP-1s mediate rescue from tauopathy

    ✓ Peer-reviewed Disease mechanisms Communications biology

    Key finding: We conducted transcriptomic analysis of tau transgenic and xbp-1s transgenic C. elegans and found 116 putative target genes significantly upregulated by constitutively active XBP-1s.

Browse the library by subject, with the full score breakdown →